Beth Giblin, PharmD
Head of Field Medical Affairs, EVERSANA, Contracted with Precigen, Inc.
Expertise:
Medical Affairs
Beth brings over 16 years of Medical Affairs experience, during which she has led Medical Strategy teams as well as Field Medical Affairs teams in support of over 10 launches in various therapeutic areas.
Articles by Beth Giblin, PharmD
SIUU vs. Unsolicited Off‑Label Requests: A Practical Comparison
posted by Beth Giblin, PharmD on April 6, 2026
As FDA regulatory expectations evolve, distinguishing between SIUU and unsolicited scientific requests is essential. This quick‑reference chart highlights the key differences between these two regulatory pathways (evidence standards, communication pathways, documentation requirements, etc.) so field teams can conduct scientific exchange confidently and compliantly. View the full side-by-side breakdown.